Evoke Pharma Inc. buy DomRuinart
Start price
18.11.20
/
50%
€32.66
Target price
18.11.21
€60.00
Performance (%)
-3.60%
End price
30.11.20
€31.49
Summary
This prediction ended on 30.11.20 with a price of €31.49. With a performance of -3.60%, the BUY prediction for Evoke Pharma Inc. by DomRuinart closed slightly in the red. DomRuinart has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evoke Pharma Inc. | - | - | - | - |
iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
According to DomRuinart what are the pros and cons of Evoke Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Evoke Pharma Inc. diskutieren
Buy mit Kursziel 5,0
In the thread Trading Evoke Pharma Inc.
Buy beendet